Target intelligence / Profile preview

Volatile sulfur compound-producing bacterial enzyme

Molecular classification
Enzyme
01

Overview

Volatile sulfur compound-producing bacterial enzymes are a functional class of enzymes expressed mainly by anaerobic Gram-negative bacteria such as Porphyromonas gingivalis, Fusobacterium nucleatum, and Treponema denticola, which are implicated in protein degradation in the oral cavity and associated with the formation of malodorous volatile sulfur compounds (VSCs) such as hydrogen sulfide and methyl mercaptan[2][5][7][1]. These VSCs are major contributors to halitosis (oral malodor) and are also linked to periodontal disease and other oral infections[5][2][1]. The most prominent enzyme activities described include cysteine desulfhydrase/cysteine lyase, methionine γ-lyase, and other proteolytic enzymes capable of liberating sulfur from amino acids[7]. These enzymes are considered therapeutic targets primarily for reducing oral malodor and possibly in the management of periodontal diseases[5][2]. The identified target is not a single canonical enzyme but a group of functionally similar bacterial enzymes; thus, the term is not a standard, singular therapeutic target and is too broad for one canonical entry—specific enzymes should be named when possible.

Other names
Volatile sulfur compound-producing enzymeVSC-producing enzymeBacterial VSC enzymeHalitosis-associated enzyme
02

Mechanism of action

Inhibition of VSC-producing enzymatic pathways reduces VSCs and ameliorates halitosis

03

Biological functions

Protein degradationAmino acid catabolismGeneration of volatile sulfur compounds
04

Disease associations

InfectionPeriodontal diseaseHalitosis
05

Safety considerations

Broad inhibition of oral microbiota can disrupt healthy floraResistance development with antibioticsPossible adverse effects with prolonged antiseptic/antimicrobial use
06

Interacting drugs

Antimicrobial mouthwashes (e.g., chlorhexidine)

2 more in the full profile.

07

Biomarkers

Levels of volatile sulfur compounds (VSCs; hydrogen sulfide, methyl mercaptan) in breathPresence of VSC-producing bacteria (e.g., Porphyromonas gingivalis, Fusobacterium nucleatum, Treponema denticola)

Beyond the preview

Go deeper on Volatile sulfur compound-producing bacterial enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Volatile sulfur compound-producing bacterial enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call